<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01457105</url>
  </required_header>
  <id_info>
    <org_study_id>A/1531/05</org_study_id>
    <nct_id>NCT01457105</nct_id>
  </id_info>
  <brief_title>Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent</brief_title>
  <official_title>PARTIALLY COVERED NITINOL &quot;ComVi&quot; STENT FOR PALLIATION OF MALIGNANT NON HILAR BILIARY OBSTRUCTION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      self-expandable metal stents for palliation of malignant biliary strictures
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ComVi biliary stent (Taewoong Medical Inc., Seoul, Korea), is a covered metallic stent
      with a expanded polytetrafluoroethylene (e-PTFE) membrane sandwiched between two wire layers
      and has a weaker axial force than other stents.

      Patients with middle-distal malignant biliary stricture and with symptoms as jaundice,
      itching and pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patency and effectiveness of the ComVi stent in palliation of jaundice in patients with malignant biliary strictures</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Malignant Biliary Strictures</condition>
  <arm_group>
    <arm_group_label>ComVi biliary stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoscopic retrograde cholangiography (ERC) (ComVi biliary stent)</intervention_name>
    <description>Metal stents placement in the main biliary duct during ERC</description>
    <arm_group_label>ComVi biliary stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with malignant stenosis at the middle or lower third of the common bile duct
             inoperable and/or unresectable.

          -  Patients without liver metastases and 6 months life expectancy

          -  Patients at the first attempt of endoscopic biliary drainage.

          -  Negative history for biliary tract surgery.

        Exclusion Criteria:

          -  Patients with ampullary cancer.

          -  Patients with hilar and/or intra-hepatic ducts malignancy.

          -  Patients with haemobilia.

          -  Patients with acute cholangitis at the time of stenting.

          -  Patients with previous percutaneous, endoscopic or surgical biliary drainage.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2011</study_first_submitted>
  <study_first_submitted_qc>October 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2011</study_first_posted>
  <last_update_submitted>October 20, 2011</last_update_submitted>
  <last_update_submitted_qc>October 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Professor Guido Costamagna</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Malignant strictures of the main biliary duct</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

